Company: PRME
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001628280-25-018704
Chunk: 36

Company: Prime Medicine, Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 36
---
 and Head of Biometrics and Data Management at Agios from August 2014 to July 2019. From February 2011 to July 2014, Dr. Goldwasser served as the U.S. Group Head of Biostatistics and Oncology Translational Medicine at Novartis International AG. Dr. Goldwasser received her Sc.D. in Biostatistics from Harvard. She holds a B.A. in Psychology from the University of Pennsylvania.

#### Andrew Anzalone, M.D., Ph.D.
joined Prime Medicine in August 2020 as Co-Founder and Head of the Prime Editing Platform. Prior to this, Dr. Anzalone was a postdoctoral researcher as a Jane Coffin Childs Memorial Fund Postdoctoral Fellow at Broad Institute. Dr. Anzalone received his Sc.B. in Chemistry from Brown University and his M.D. and Ph.D. from Columbia University.

<div align='center'>23</div>

### EXECUTIVE COMPENSATION
This section provides an overview of the compensation awarded to, earned by, or paid to our principal executive officer and our two most highly compensated executive officers (other than our principal executive officer) who were serving as executive officers at the end of 2024, in respect of their service to us for the fiscal year ended December 31, 2024 . We refer to these individuals as our NEOs. Our NEOs for the fiscal year ended December 31, 2024 were:

• Keith Gottesdiener, M.D., our President and Chief Executive Officer;

• Allan Reine, M.D., our Chief Financial Officer; and

• Jeremy Duffield, M.D., Ph.D., FRCP, our Chief Scientific Officer

#### 2024 Summary Compensation Table
The following table sets forth the compensation provided to our NEOs for the fiscal years ended December 31, 2024 and 2023.

| Name and Principal Position        |     | Year |     | Salary 
 ($)    |         |     | Bonus 
 ($)   |         |     | Option  
 Awards  
 ($) (1) |           |     | Non-Equity     
 Incentive Plan 
 Compensation   
 ($) (2)        |         |     | All Other    
 Compensation 
 ($)          |        |     | Total 
 ($)   |           |
| Keith Gottesdiener, M.D.           
 (3)                                |     | 2024 |     |        | 652,792 |     |